Cargando…
The Efficacy of Angiotensin Receptor-Neprilysin Inhibitor Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Post Myocardial Infarction: A Meta-Analysis
Acute myocardial infarction (MI) is one of the leading global healthcare emergencies, contributing to over three million global deaths. The purpose of this study is to investigate further the efficacy of sacubitril/valsartan over angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin recept...
Autores principales: | Kotak, Sohny, Hassan, Warda, Mehmood, Marium, Kumar, Umesh, Sagreeka, FNU, Karishma, FNU, Kumari, Pirya, Pirya, FNU, Saquib, Javeria, Iqbal, Amna, Khan, Anosh Aslam, Varrassi, Giustino, Khatri, Mahima, Kumar, Satesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625497/ https://www.ncbi.nlm.nih.gov/pubmed/37933369 http://dx.doi.org/10.7759/cureus.46547 |
Ejemplares similares
-
Angiotensin receptor blocker neprilysin inhibitors
por: Usuda, Daisuke, et al.
Publicado: (2021) -
Angiotensin receptor-neprilysin inhibitors and cardiac remodeling
por: Ryazanov, A.S., et al.
Publicado: (2023) -
Angiotensin Receptor-Neprilysin Inhibitor (ARNI) and Cardiac Arrhythmias
por: Sutanto, Henry, et al.
Publicado: (2021) -
Comparison of Efficacy and Safety of Angiotensin Receptor-Neprilysin Inhibitors in Patients With Heart Failure With Reduced Ejection Fraction: A Meta-Analysis
por: Haseeb, Muhammad Talha, et al.
Publicado: (2023) -
Advances in the Management of Diabetes Mellitus: A Focus on Personalized Medicine
por: Sugandh, FNU, et al.
Publicado: (2023)